Average Americans Show Compassion for their Fellow Citizens Who Can’t Afford Medication – What About Our Elected Officials?

Two years ago, ABC News ran a segment (What Would You Do?) that showed Americans going out of their way to help strangers who could not afford their medication. Actors visited local pharmacies pretending they could not afford to pay for their much-needed prescription drugs – something that happens frequently in the U.S. Some people offered to help pay for part or all of the drug orders, and one man even left the pharmacy to get money from an ATM. In addition to financial assistance, these individuals also offered words of solidarity against the outrageous costs. Karen Wenberg (real person) told the woman (actress) she was helping: “Don’t be embarrassed. You know what? Medication is so f***ing expensive. There is no reason to be embarrassed… Sometimes we just pass on the good that’s been given to us.”

As we write this, Congress is marking up a new law, Stop Online Piracy Act (SOPA), one supported by the Obama administration that could effectively block Americans from acquiring safe and affordable medication from online pharmacies outside the U.S. As the government seeks to rein in spending, why do they want to stop consumers from getting non-tax-payer funded, affordable medication? When people go without medication, they can become sick or get sicker, putting a great burden on the health care system. To see what the government is doing, read RxRight.org’s guest post on techdirt. (more…)

Share

UPDATED: August 24, 2011, 6:30pm

The United States Department of Justice just announced that Google will be paying a $500 million penalty to the U.S. government for allowing Canadian pharmacies to advertise to Americans. We are familiar with this case, having been asked to testify in it – and we are mentioned several times in the settlement.

Although we tried to help Google vet pharmacy advertisers from 2006 to 2009, it is clear that Google was not limiting pharmacy advertisers to just those verified in our Pharmacy Verification Program – as noted on pages 4 and 5 of the settlement. That was bad because it allowed advertising by pharmacies that did not require valid U.S. prescriptions and/or sold controlled substances into the U.S.  – activities which we do not permit in our program. As noted on page 6 of the settlement, the $500 million amount is based on revenues generated from the advertising and sales of “controlled” substances, not all medicines.

On the other hand, we believe that efforts to help Americans find more affordable and safe sources of medication are necessary and should be praised. And Google also did that: Although it can’t anymore – at least not through advertisements  – and we think that’s wrong.

Unfortunately, the Department of Justice is publicizing the settlement in a misleading manner that paints all non-U.S. online pharmacies as “patently unsafe,” and “contributing to America’s pill problem”.  Peer-reviewed research shows that buying prescription medications from licensed pharmacies in other countries, and specifically those verified in the PharmacyChecker.com Verification Program, is safe. Genuine medicines (and no controlled substances) are obtained, typically at savings of 80% or more on brand name medications – and prescriptions are required.  Also, while the DOJ’s announcement emphasizes the illegality of personal drug importation, it fails to mention that individuals, as a matter of FDA’s policies, are not prosecuted for buying non-controlled drugs from outside the U.S. for their own use.

An FDA representative says in today’s announcement that the settlement “demonstrates the commitment of the Food and Drug Administration to protect the US consumer and hold all contributing parties accountable for conduct that results in vast profits at the expense of public health.” While this is in part true, it ignores the fact that much greater profits are being made by pharmaceutical companies at the expense of public health by keeping Americans captive to inflated drug prices. As the Centers for Disease Control and Prevention recently reported, 25 million Americans did not take their prescribed medication due to cost in 2009, almost double the number in 1997. Personal drug importation from properly verified and reputable Canadian online pharmacies clearly benefits public health by making drugs more affordable for Americans.

For a take on this situation from the perspective of a knowledgeable physician who purchases his own medicine from abroad, see the recent article by Stephen Barrett, M.D., founder of Pharmwatch.org and Quackwatch.org.

Share

Beware of Fake DEA Agent Online Pharmacy Scam

A recent article in The Muskegon Chronicle warns of a new scam against consumers who buy prescription drugs online. The Chronicle reports:

Some people who bought prescriptions online later received calls from someone claiming to be an agent of the Drug Enforcement Agency, who demanded they wire a “fine” to avoid being arrested.

Anyone receiving a telephone call from a person claiming to be a DEA special agent or other law enforcement official seeking money should refuse the demand and report the threat by calling 1-877-792-2873.

While buying drugs online from Canada and other countries is, under most circumstances, technically illegal, individuals who import non-controlled products for their own personal use are not prosecuted. There is no reason whatsoever that a DEA or FDA agent would contact someone who purchased controlled or regular prescription drugs online asking for, or demanding payment of, a fine. Just as the article suggests, if you are targeted in this fake DEA scam, please report the threat to law enforcement officials immediately.

As a reminder, reputable international online pharmacies do not sell controlled substances to Americans. Federal law, under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, mandates that only U.S. pharmacies with a DEA license can sell controlled substances online, pursuant to a valid prescription based on face-to-face consultation with a licensed U.S. physician. Learn more about buying controlled substances online.

 

 

Share

Per the FDA’s invitation for regulation reviews and comments as listed by the Federal Registrar, our vice president, Gabriel Levitt, submitted PharmacyChecker.com’s positions and suggestions pertaining to online pharmacies and personal drug importation.

Our first point is that there is inaccurate information provided for consumers on the FDA’s website relating to online pharmacies and drug safety. Consumers are misled to believe that any pharmacy not located in the United States is dangerous, or non-reputable, while experience and studies show that properly verified international online pharmacies are safe. Additionally, the FDA’s website communicates that only FDA-approved drugs are checked for safety and effectiveness, a claim for which there is no basis. In fact, some so-called “non FDA-approved” drugs are the exact same drugs made by Pfizer or Merck, for example, just labeled or colored differently.

We then recommend revisions to Section 9.2 of the FDA Regulatory Procedures Manual Imports and Exports, which guides FDA practices in enforcing our drug importation laws. We recommend that FDA’s personal drug importation policy explicitly disallow government officials from seizing personally imported prescription orders destined for Americans that they know are genuine and dispensed pursuant to a prescription. The ethical and economic basis for our recommendation is that prescription non-adherence (not taking your meds) often furthers illness, leading to more emergency room visits, costing the nation hundreds of billions in healthcare dollars.

Finally, we ask that the FDA ban enforcement actions against foreign companies that are known to operate safe international mail-order pharmacies. Studies show that cost is the number one reason that Americans do not take their medications, and cutting off access to these safe and affordable pharmacies means fewer Americans will take their prescribed medicines.

Our full submission can be accessed here.

Share

A new post on RxRights.org explains how the National Association of Boards of Pharmacy (NABP)’s Internet Drug Outlet Identification Program wrongly misleads consumers and the media by tagging all non-U.S. online pharmacies that sell to Americans as “rogue.” Essentially, that program’s list includes dangerous rogue online pharmacies along with reputable online pharmacies that meet high standards of safety but are simply not based in the United States. American consumers should expect more from pharmacy regulatory authorities and deserve to be properly informed. By adding properly verified international online pharmacies to the list, NABP scares Americans away from safe and affordable sources of medication. RxRight.org alerts the public that NABP’s program was sponsored with a grant from the drug giant Pfizer.

The post also deconstructs the ridiculous notion that only “FDA-approved” drugs are safe.  It explains that the same exact drug purchased from a Canadian pharmacy (or any non-U.S. pharmacy) that is sold in the United States is “Not FDA-approved.” How can that be if it’s the same drug? There are many reasons, but one primary reason is labeling. FDA-approved drugs include approval of the drug’s specific labeling. That means that virtually all drugs sold in Canada that are compositionally identical to those sold in the United States are not “FDA-approved” because their labeling is different (such as including information in French and English), but of course they are equally as safe.

PharmacyChecker.com applauds RxRights.org for exposing misinformation campaigns sponsored by the pharmaceutical industry meant to scare Americans away from safe and affordable online pharmacies, wrongly inform the media, and shape our nation’s laws and regulations.

Share

We’re proud to announce our support for RxRights (www.RxRights.org), a non-profit group dedicated to protecting access to safe and affordable personal drug importation through verified online pharmacies.  PharmacyChecker.com is a coalition member of RxRights.org, which harnesses the non-profit community and American consumers in a shared effort to stand up and demand that our leaders listen to the American people instead of playing to the dictates of the pharmaceutical industry.

Go to RxRights.org advocacy campaign page, to send a message to your elected representatives.  Tell them that the U.S. government should not take actions that could block access to safe and affordable medication.

Share

For the past decade, millions of Americans have safely purchased low-priced medications from Canadian and other non-U.S. online pharmacies. Now it appears that the White House Office of the Intellectual Property Rights seeks to shutdown such online pharmacies because they are not on a “White List” being created by the National Association of Boards of Pharmacy (NABP), an organization that misleadingly categorizes all non-U.S. online pharmacies that sell to Americans as “rogue.” Already, 25 million Americans do not take their medication due to cost. With less access to affordable medication, fewer Americans will take the medications they need.

We urge you to write to President Obama and your congressional representatives, and demand that actions are not taken against online pharmacies that safely provide affordable medication.

For more news on this advocacy initiative, click here.

Share

Drug Importation Bill Introduced by Senator Olympia Snowe

Last May, we reported that AARP honored Senator Olympia Snowe (R- Maine) for her ongoing advocacy of policies and initiatives that seek to improve the lives of Americans age 50-plus. The award specifically mentioned her efforts to make safe drug importation legal and more available to help more Americans afford their medication. In our post on this recognition, we predicted that the issue of access to safe drugs would persist in the aftermath of the new healthcare legislation, and we’re now happy to announce that last week Senator Snowe put legalizing drug importation back on the Senate’s agenda.

Senator Snowe has introduced legislation that would amend the Food, Drug, and Cosmetic act to facilitate drug importation that would effectively lower prescription drug prices. Additionally, the bill would increase U.S. Food and Drug Administration inspections of international manufacturing plants. S. 319, the proposed Pharmaceutical Market Access and Drug Safety Act of 2011, is similar to Senator Snowe’s co-sponsored bill from 2009, also known as the Dorgan Amendment. For more information on the Senator’s past support for personal drug importation, see our post Canadian Pharmacies and Personal Drug Importation Play Critical Role in Greater Healthcare Benefits for Americans. (more…)

Share

Last week, YouTube hosted a question and answer session at the White House with President Barack Obama. Americans across the country submitted over 140,000 questions to YouTube, and over a million people voted on which of those questions moderator Steve Grove should ask the president. We were not surprised to find out that the top healthcare question related to none other than prescription drug prices and importation:

Why [does] the same medication that I use cost so much less in Mexico or Canada even though it is being made here in the United States? (Noah, 00:29:03)

Obama’s answer was upfront and honest, and frankly, we liked what he had to say. The president said, “Canada and Mexico are bulk purchasers of those drugs, so they negotiate much cheaper drug prices with the drug companies. We still don’t do that, and I actually think it’s something we should do – it would save us money.” We were also pleased to hear him reopening communication about drug importation. “It may be that importation is still something we should look at in terms of further lowering the price of drugs,” the president said. (more…)

Share

A new SmartMoney.com article entitled Ten Things the FDA Won’t Tell You reaffirms what we’ve reported in the past – when it comes to drug importation for personal use, the FDA generally does not intervene. “Feel free to buy drugs across the border,” the article’s subhead reads. And the FDA confirms, “The agency focuses enforcement only on imports that are intended for resale.”

However, purchasing imported or domestically sold drugs through online pharmacies requires consumer caution, as fraudulent rogue online pharmacies abound. Importantly, the SmartMoney article also references a study conducted by Roger Bate of the American Enterprise Institute and published in the Public Library of Science, which confirmed that drugs sold on the internet that had been properly verified by either the PharmacyChecker.com Verification Program or the National Association of Boards of Pharmacy’s VIPPS Program sell genuine medication and require a prescription. (more…)

Share
Get Adobe Flash playerPlugin by wpburn.com wordpress themes